1991
DOI: 10.1111/j.1365-2273.1991.tb01051.x
|View full text |Cite
|
Sign up to set email alerts
|

Ploidy in head and neck cancer: a review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

1992
1992
2000
2000

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(9 citation statements)
references
References 25 publications
1
8
0
Order By: Relevance
“…This points to an early accumulation of generalized genetic changes in head and neck tumorigenesis, and indicates that the detection of chromosomal aberrations in cytologic specimens is a relevant marker for risk assessment in (pre)clinical stages of this disease. Studies using flow cytometry to measure the DNA content of HNSCC showed that 60‐70% of these tumors were DNA aneuploid 12. In the current study 9 of 12 analyzed solid tumor tissue specimens showed DNA aneuploidy (75%) and chromosomal aberrations were detected in all these tissue specimens.…”
Section: Discussionsupporting
confidence: 93%
“…This points to an early accumulation of generalized genetic changes in head and neck tumorigenesis, and indicates that the detection of chromosomal aberrations in cytologic specimens is a relevant marker for risk assessment in (pre)clinical stages of this disease. Studies using flow cytometry to measure the DNA content of HNSCC showed that 60‐70% of these tumors were DNA aneuploid 12. In the current study 9 of 12 analyzed solid tumor tissue specimens showed DNA aneuploidy (75%) and chromosomal aberrations were detected in all these tissue specimens.…”
Section: Discussionsupporting
confidence: 93%
“…'~ In the current study, a modified system was used, originally designed for oral squamous cell carcinoma, and including three variables for each tumor cell population and each tumor-host relationship. *' Each variable was rated on a 4-point scale (1)(2)(3)(4), the aggregate score thus ranging from 6-24 points depending on the tumor's malignancy grade ( Table 2). The variables were adapted in such a way that all types of squamous cell carcinoma could be fitted in to the scheme.…”
Section: Histopathologic Malignancy Gradementioning
confidence: 99%
“…However, Kokal, et al 4 noted that patients with aneuploid squamous cell carcinoma had significantly decreased relapse‐free and overall survival rates compared to patients with diploid tumors. In other studies, 7 aneuploidy was found to be of no importance in predicting clinical outcome.…”
Section: Introductionmentioning
confidence: 77%